Sponsor Pipeline

Nanolattix Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07434609 Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With… Advanced Solid Tumor (Phase 1) Not Yet Recruiting
Early Phase 1
NCT07505069 Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors Solid Tumors Recruiting
Get alerts when Nanolattix Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free